Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More information21st October 2020
This guidance currently covers Article 41. We will update this guidance to cover all aspects of supplying medicines to Northern Ireland from 1 January 2021 in due course.
Goods placed on the market in the European Union or the United Kingdom before the end of the transition period may continue to circulate between these two markets from 1 January 2021. This includes medicines moving from Great Britain to Northern Ireland.
This is stated in Article 41 of the EU Withdrawal Agreement.
A medicine is ‘placed on the market’ if it is available for sale or supply and there has been a written or verbal agreement (or offer of an agreement) to transfer ownership of the medicine to another legal entity.
Placing a manufacturing order for completion after 11pm on 31 December 2020 is insufficient to qualify for continued circulation. The medicine must have been manufactured and QP certified.